Back
BridgeBio Pharma, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
48
BBIO
BridgeBio Pharma, Inc.
Last Price:
$76.33
Seasonality Move:
-13.18%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBridgeBio Pharma, Inc. Stock Forecast
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 71.6% based on the past 6 years of stock performance.
-
BridgeBio Pharma, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is BridgeBio Pharma, Inc. Stock Undervalued?The current BridgeBio Pharma, Inc. [BBIO] share price is $76.30. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will BridgeBio Pharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BridgeBio Pharma, Inc. has on average historically risen by 71.6% based on the past 6 years of stock performance.
BridgeBio Pharma, Inc. Stock Rating
Sell
48
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. overpriced?
-
BridgeBio Pharma, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
BridgeBio Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com
52-Week Data
52-Week High:
77.20
52-Week Low:
26.02
Prediction Charts
Market Cap:
14.7B
Price in USD:
76.30
Volume:
4.7M
Beta:
1.06
Technical Analysis
SMA50:
65.78
SMA100:
58.31
SMA200:
48.11
52-Wk Change:
191.11%
Stock Predictions
-
Is BridgeBio Pharma, Inc. stock public?Yes, BridgeBio Pharma, Inc. is a publicly traded company.
-
What is the BridgeBio Pharma, Inc. stock quote today?The BridgeBio Pharma, Inc. stock price is 76.30 USD today.
-
How to buy BridgeBio Pharma, Inc. stock online?You can buy BridgeBio Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 72.17 | 71.46 | 73.45 | 71.35 |
| Dec-3 | 71.94 | 74.15 | 74.34 | 71.16 |
| Dec-4 | 74.01 | 74.76 | 75.04 | 72.48 |
| Dec-5 | 74.40 | 73.64 | 74.86 | 72.38 |
| Dec-8 | 74.26 | 74.24 | 75.10 | 73.70 |
| Dec-9 | 74.05 | 71.67 | 74.72 | 71.47 |
| Dec-10 | 71.46 | 72.70 | 73.06 | 70.35 |
| Dec-11 | 74.01 | 74.07 | 74.27 | 72.42 |
| Dec-12 | 73.83 | 75.15 | 75.24 | 72.65 |
| Dec-15 | 74.96 | 74.51 | 75.61 | 73.95 |
| Dec-16 | 73.49 | 75.69 | 76.51 | 72.73 |
| Dec-17 | 75.32 | 74.02 | 75.74 | 73.95 |
| Dec-18 | 75.36 | 74.14 | 75.92 | 73.48 |
| Dec-19 | 74.44 | 76.30 | 77.20 | 74.20 |
BridgeBio Pharma, Inc. Earnings
BridgeBio Pharma, Inc. Earnings Report: Per Share BridgeBio Pharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BridgeBio Pharma, Inc. Forecast Revenue Growth
BridgeBio Pharma, Inc. Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $1.42 per share.
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.